
Risk scores, prevention, and treatment of maternal venous thromboembolism
Author(s) -
Wei Zhang,
Jian Shen,
Jingli Sun
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i11.2210
Subject(s) - medicine , pregnancy , pulmonary embolism , caesarean section , asymptomatic , pediatrics , venous thrombosis , obstetrics , thrombosis , surgery , genetics , biology
At present, the preventive treatment for pregnancy-related venous thromboembolism (VTE) in China is in its infancy, and there is no uniform or standardized industry guide. Drug prevention and treatment of pregnancy-related VTE rely highly on foreign guidelines; however, due to the differences in ethnicity and national conditions, there are many controversies over the indications for drug treatment, drug selection, and dose selection for anticoagulant therapy.